Monoclonal antibodies the subject of PhD research at Sanofi and LMGP
Categorie(s) : Education, Industry, News, Research
Published : 6 December 2021
Surfactants can limit this phenomenon, helping maintain the monoclonal antibodies’ efficacy. The PhD candidate’s research will focus on understanding the adsorption process and determining which materials are most compatible. For LMGP, the project represents a rare opportunity step away from model proteins and work on a pharmaceutical company’s “real” ones.